Global Addictions Therapeutics Market Insights, Forecast to 2028

Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.

Market Analysis and Insights: Global Addictions Therapeutics Market

The global Addictions Therapeutics market size is projected to reach US$ 6401.2 million by 2028, from US$ 4745.6 million in 2021, at a CAGR of 4.3% during 2022-2028.

With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Addictions Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Addictions Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Addictions Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Addictions Therapeutics market.

Global Addictions Therapeutics Scope and Market Size

Addictions Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Alcohol Addiction Therapeutics

Tobacco Addiction Therapeutics

Drug Addiction Therapeutics

Public

Private

Government

Alkermes Plc

Amneal Pharmaceuticals Inc.

Indivior Plc

Johnson & Johnson Services Inc.

Mylan NV

Novartis AG

Novo Nordisk AS

Opiant Pharmaceuticals Inc.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Addictions Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Alcohol Addiction Therapeutics

1.2.3 Tobacco Addiction Therapeutics

1.2.4 Drug Addiction Therapeutics

1.3 Market by Application

1.3.1 Global Addictions Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Public

1.3.3 Private

1.3.4 Government

1.4 Study Objectives

1.5 Years Considered

2.1 Global Addictions Therapeutics Market Perspective (2017-2028)

2.2 Addictions Therapeutics Growth Trends by Region

2.2.1 Addictions Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Addictions Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Addictions Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Addictions Therapeutics Market Dynamics

2.3.1 Addictions Therapeutics Industry Trends

2.3.2 Addictions Therapeutics Market Drivers

2.3.3 Addictions Therapeutics Market Challenges

2.3.4 Addictions Therapeutics Market Restraints

3.1 Global Top Addictions Therapeutics Players by Revenue

3.1.1 Global Top Addictions Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Addictions Therapeutics Revenue

3.4 Global Addictions Therapeutics Market Concentration Ratio

3.4.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2021

3.5 Addictions Therapeutics Key Players Head office and Area Served

3.6 Key Players Addictions Therapeutics Product Solution and Service

3.7 Date of Enter into Addictions Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Addictions Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2023-2028)

5.1 Global Addictions Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2023-2028)

6.1 North America Addictions Therapeutics Market Size (2017-2028)

6.2 North America Addictions Therapeutics Market Size by Type

6.2.1 North America Addictions Therapeutics Market Size by Type (2017-2022)

6.2.2 North America Addictions Therapeutics Market Size by Type (2023-2028)

6.2.3 North America Addictions Therapeutics Market Share by Type (2017-2028)

6.3 North America Addictions Therapeutics Market Size by Application

6.3.1 North America Addictions Therapeutics Market Size by Application (2017-2022)

6.3.2 North America Addictions Therapeutics Market Size by Application (2023-2028)

6.3.3 North America Addictions Therapeutics Market Share by Application (2017-2028)

6.4 North America Addictions Therapeutics Market Size by Country

6.4.1 North America Addictions Therapeutics Market Size by Country (2017-2022)

6.4.2 North America Addictions Therapeutics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Addictions Therapeutics Market Size (2017-2028)

7.2 Europe Addictions Therapeutics Market Size by Type

7.2.1 Europe Addictions Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe Addictions Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe Addictions Therapeutics Market Share by Type (2017-2028)

7.3 Europe Addictions Therapeutics Market Size by Application

7.3.1 Europe Addictions Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe Addictions Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe Addictions Therapeutics Market Share by Application (2017-2028)

7.4 Europe Addictions Therapeutics Market Size by Country

7.4.1 Europe Addictions Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe Addictions Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Addictions Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Addictions Therapeutics Market Size by Type

8.2.1 Asia-Pacific Addictions Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Addictions Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Addictions Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific Addictions Therapeutics Market Size by Application

8.3.1 Asia-Pacific Addictions Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Addictions Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Addictions Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific Addictions Therapeutics Market Size by Region

8.4.1 Asia-Pacific Addictions Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Addictions Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Addictions Therapeutics Market Size (2017-2028)

9.2 Latin America Addictions Therapeutics Market Size by Type

9.2.1 Latin America Addictions Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America Addictions Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America Addictions Therapeutics Market Share by Type (2017-2028)

9.3 Latin America Addictions Therapeutics Market Size by Application

9.3.1 Latin America Addictions Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America Addictions Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America Addictions Therapeutics Market Share by Application (2017-2028)

9.4 Latin America Addictions Therapeutics Market Size by Country

9.4.1 Latin America Addictions Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America Addictions Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Addictions Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Addictions Therapeutics Market Size by Type

10.2.1 Middle East & Africa Addictions Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Addictions Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Addictions Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa Addictions Therapeutics Market Size by Application

10.3.1 Middle East & Africa Addictions Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Addictions Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Addictions Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa Addictions Therapeutics Market Size by Country

10.4.1 Middle East & Africa Addictions Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Addictions Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Alkermes Plc

11.1.1 Alkermes Plc Company Details

11.1.2 Alkermes Plc Business Overview

11.1.3 Alkermes Plc Addictions Therapeutics Introduction

11.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2017-2022)

11.1.5 Alkermes Plc Recent Developments

11.2 Amneal Pharmaceuticals Inc.

11.2.1 Amneal Pharmaceuticals Inc. Company Details

11.2.2 Amneal Pharmaceuticals Inc. Business Overview

11.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction

11.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2017-2022)

11.2.5 Amneal Pharmaceuticals Inc. Recent Developments

11.3 Indivior Plc

11.3.1 Indivior Plc Company Details

11.3.2 Indivior Plc Business Overview

11.3.3 Indivior Plc Addictions Therapeutics Introduction

11.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2017-2022)

11.3.5 Indivior Plc Recent Developments

11.4 Johnson & Johnson Services Inc.

11.4.1 Johnson & Johnson Services Inc. Company Details

11.4.2 Johnson & Johnson Services Inc. Business Overview

11.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction

11.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2017-2022)

11.4.5 Johnson & Johnson Services Inc. Recent Developments

11.5 Mylan NV

11.5.1 Mylan NV Company Details

11.5.2 Mylan NV Business Overview

11.5.3 Mylan NV Addictions Therapeutics Introduction

11.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2017-2022)

11.5.5 Mylan NV Recent Developments

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Addictions Therapeutics Introduction

11.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2017-2022)

11.6.5 Novartis AG Recent Developments

11.7 Novo Nordisk AS

11.7.1 Novo Nordisk AS Company Details

11.7.2 Novo Nordisk AS Business Overview

11.7.3 Novo Nordisk AS Addictions Therapeutics Introduction

11.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2017-2022)

11.7.5 Novo Nordisk AS Recent Developments

11.8 Opiant Pharmaceuticals Inc.

11.8.1 Opiant Pharmaceuticals Inc. Company Details

11.8.2 Opiant Pharmaceuticals Inc. Business Overview

11.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction

11.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2017-2022)

11.8.5 Opiant Pharmaceuticals Inc. Recent Developments

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Details

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Addictions Therapeutics Introduction

11.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2017-2022)

11.9.5 Pfizer Inc. Recent Developments

11.10 Teva Pharmaceutical Industries Ltd.

11.10.1 Teva Pharmaceutical Industries Ltd. Company Details

11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction

11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2017-2022)

11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Addictions Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Alcohol Addiction Therapeutics

    Table 3. Key Players of Tobacco Addiction Therapeutics

    Table 4. Key Players of Drug Addiction Therapeutics

    Table 5. Global Addictions Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Addictions Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Addictions Therapeutics Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Addictions Therapeutics Market Share by Region (2017-2022)

    Table 9. Global Addictions Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Addictions Therapeutics Market Share by Region (2023-2028)

    Table 11. Addictions Therapeutics Market Trends

    Table 12. Addictions Therapeutics Market Drivers

    Table 13. Addictions Therapeutics Market Challenges

    Table 14. Addictions Therapeutics Market Restraints

    Table 15. Global Addictions Therapeutics Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Addictions Therapeutics Revenue Share by Players (2017-2022)

    Table 17. Global Top Addictions Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Addictions Therapeutics as of 2021)

    Table 18. Ranking of Global Top Addictions Therapeutics Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Addictions Therapeutics Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Addictions Therapeutics Product Solution and Service

    Table 22. Date of Enter into Addictions Therapeutics Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Addictions Therapeutics Revenue Market Share by Type (2017-2022)

    Table 26. Global Addictions Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Addictions Therapeutics Revenue Market Share by Type (2023-2028)

    Table 28. Global Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Addictions Therapeutics Revenue Share by Application (2017-2022)

    Table 30. Global Addictions Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Addictions Therapeutics Revenue Share by Application (2023-2028)

    Table 32. North America Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 33. North America Addictions Therapeutics Market Size by Type (2023-2028) & (US$ Million)

    Table 34. North America Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 35. North America Addictions Therapeutics Market Size by Application (2023-2028) & (US$ Million)

    Table 36. North America Addictions Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 37. North America Addictions Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 38. Europe Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 39. Europe Addictions Therapeutics Market Size by Type (2023-2028) & (US$ Million)

    Table 40. Europe Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 41. Europe Addictions Therapeutics Market Size by Application (2023-2028) & (US$ Million)

    Table 42. Europe Addictions Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 43. Europe Addictions Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Addictions Therapeutics Market Size by Type (2023-2028) & (US$ Million)

    Table 46. Asia Pacific Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 47. Asia Pacific Addictions Therapeutics Market Size by Application (2023-2028) & (US$ Million)

    Table 48. Asia Pacific Addictions Therapeutics Market Size by Region (2017-2022) & (US$ Million)

    Table 49. Asia Pacific Addictions Therapeutics Market Size by Region (2023-2028) & (US$ Million)

    Table 50. Latin America Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Addictions Therapeutics Market Size by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Addictions Therapeutics Market Size by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Addictions Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Addictions Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Addictions Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Addictions Therapeutics Market Size by Type (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Addictions Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Addictions Therapeutics Market Size by Application (2023-2028) & (US$ Million)

    Table 60. Middle East and Africa Addictions Therapeutics Market Size by Country (2017-2022) & (US$ Million)

    Table 61. Middle East and Africa Addictions Therapeutics Market Size by Country (2023-2028) & (US$ Million)

    Table 62. Alkermes Plc Company Details

    Table 63. Alkermes Plc Business Overview

    Table 64. Alkermes Plc Addictions Therapeutics Product

    Table 65. Alkermes Plc Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 66. Alkermes Plc Recent Developments

    Table 67. Amneal Pharmaceuticals Inc. Company Details

    Table 68. Amneal Pharmaceuticals Inc. Business Overview

    Table 69. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product

    Table 70. Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 71. Amneal Pharmaceuticals Inc. Recent Developments

    Table 72. Indivior Plc Company Details

    Table 73. Indivior Plc Business Overview

    Table 74. Indivior Plc Addictions Therapeutics Product

    Table 75. Indivior Plc Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 76. Indivior Plc Recent Developments

    Table 77. Johnson & Johnson Services Inc. Company Details

    Table 78. Johnson & Johnson Services Inc. Business Overview

    Table 79. Johnson & Johnson Services Inc. Addictions Therapeutics Product

    Table 80. Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 81. Johnson & Johnson Services Inc. Recent Developments

    Table 82. Mylan NV Company Details

    Table 83. Mylan NV Business Overview

    Table 84. Mylan NV Addictions Therapeutics Product

    Table 85. Mylan NV Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 86. Mylan NV Recent Developments

    Table 87. Novartis AG Company Details

    Table 88. Novartis AG Business Overview

    Table 89. Novartis AG Addictions Therapeutics Product

    Table 90. Novartis AG Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 91. Novartis AG Recent Developments

    Table 92. Novo Nordisk AS Company Details

    Table 93. Novo Nordisk AS Business Overview

    Table 94. Novo Nordisk AS Addictions Therapeutics Product

    Table 95. Novo Nordisk AS Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 96. Novo Nordisk AS Recent Developments

    Table 97. Opiant Pharmaceuticals Inc. Company Details

    Table 98. Opiant Pharmaceuticals Inc. Business Overview

    Table 99. Opiant Pharmaceuticals Inc. Addictions Therapeutics Product

    Table 100. Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 101. Opiant Pharmaceuticals Inc. Recent Developments

    Table 102. Pfizer Inc. Company Details

    Table 103. Pfizer Inc. Business Overview

    Table 104. Pfizer Inc. Addictions Therapeutics Product

    Table 105. Pfizer Inc. Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 106. Pfizer Inc. Recent Developments

    Table 107. Teva Pharmaceutical Industries Ltd. Company Details

    Table 108. Teva Pharmaceutical Industries Ltd. Business Overview

    Table 109. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product

    Table 110. Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2017-2022) & (US$ Million)

    Table 111. Teva Pharmaceutical Industries Ltd. Recent Developments

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Addictions Therapeutics Market Share by Type: 2021 VS 2028

    Figure 2. Alcohol Addiction Therapeutics Features

    Figure 3. Tobacco Addiction Therapeutics Features

    Figure 4. Drug Addiction Therapeutics Features

    Figure 5. Global Addictions Therapeutics Market Share by Application: 2021 VS 2028

    Figure 6. Public Case Studies

    Figure 7. Private Case Studies

    Figure 8. Government Case Studies

    Figure 9. Addictions Therapeutics Report Years Considered

    Figure 10. Global Addictions Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Addictions Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Addictions Therapeutics Market Share by Region: 2021 VS 2028

    Figure 13. Global Addictions Therapeutics Market Share by Players in 2021

    Figure 14. Global Top Addictions Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Addictions Therapeutics as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Addictions Therapeutics Revenue in 2021

    Figure 16. North America Addictions Therapeutics Market Size YoY (2017-2028) & (US$ Million)

    Figure 17. North America Addictions Therapeutics Market Size Market Share by Type (2017-2028)

    Figure 18. North America Addictions Therapeutics Market Size Market Share by Application (2017-2028)

    Figure 19. North America Addictions Therapeutics Market Size Share by Country (2017-2028)

    Figure 20. United States Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Canada Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. Europe Addictions Therapeutics Market Size YoY (2017-2028) & (US$ Million)

    Figure 23. Europe Addictions Therapeutics Market Size Market Share by Type (2017-2028)

    Figure 24. Europe Addictions Therapeutics Market Size Market Share by Application (2017-2028)

    Figure 25. Europe Addictions Therapeutics Market Size Share by Country (2017-2028)

    Figure 26. Germany Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. France Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. U.K. Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Italy Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Russia Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Nordic Countries Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Asia-Pacific Addictions Therapeutics Market Size YoY (2017-2028) & (US$ Million)

    Figure 33. Asia Pacific Addictions Therapeutics Market Size Market Share by Type (2017-2028)

    Figure 34. Asia Pacific Addictions Therapeutics Market Size Market Share by Application (2017-2028)

    Figure 35. Asia Pacific Addictions Therapeutics Market Size Share by Region (2017-2028)

    Figure 36. China Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Japan Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. South Korea Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Southeast Asia Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. India Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Australia Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 42. Latin America Addictions Therapeutics Market Size YoY (2017-2028) & (US$ Million)

    Figure 43. Latin America Addictions Therapeutics Market Size Market Share by Type (2017-2028)

    Figure 44. Latin America Addictions Therapeutics Market Size Market Share by Application (2017-2028)

    Figure 45. Latin America Addictions Therapeutics Market Size Share by Country (2017-2028)

    Figure 46. Mexico Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Brazil Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 48. Middle East & Africa Addictions Therapeutics Market Size YoY (2017-2028) & (US$ Million)

    Figure 49. Middle East and Africa Addictions Therapeutics Market Size Market Share by Type (2017-2028)

    Figure 50. Middle East and Africa Addictions Therapeutics Market Size Market Share by Application (2017-2028)

    Figure 51. Middle East and Africa Addictions Therapeutics Market Size Share by Country (2017-2028)

    Figure 52. Turkey Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. Saudi Arabia Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. UAE Addictions Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 55. Alkermes Plc Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 56. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 57. Indivior Plc Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 58. Johnson & Johnson Services Inc. Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 59. Mylan NV Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 60. Novartis AG Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 61. Novo Nordisk AS Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 62. Opiant Pharmaceuticals Inc. Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 63. Pfizer Inc. Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 64. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Addictions Therapeutics Business (2017-2022)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed